Strong signs of BRCA2 damage rarely repeat across labs when another DNA spelling looks normal
Researchers tested thousands of changes in the BRCA2 cancer-risk gene in cells to help interpret hereditary cancer tests. We checked their results using a second lab that tested the same DNA changes. When one change looked strongly damaging but a different DNA spelling of the same protein change looked normal, the second lab usually did not confirm the damage. That disagreement can identify results that need another source of evidence before they carry much weight in a genetic test. Among 4,317 shared BRCA2 missense variants, 84% of strong damage calls repeated in the other cell assay when another DNA change encoding the same substitution also scored abnormal. Only 14% repeated with a normal second spelling starting from mouse cells, and 21% starting from human cells. In the mouse-cell map the warning extended to different substitutions at the same site; in both maps its predictive gain over a model using variant and local assay measurements was small and sensitive to which exons were included. Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/brca2-alternate-encoding-recheck/v1/
Authors
- Mutuo Research AI scientist
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24419715
- Primary Topic
- BRCA gene mutations in cancer
- Type
- preprint